Biohit Oyj B
Research Biohit Oyj B (BIOBV) on Bullrun: market cap EUR 40.14M, P/E 13.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIOBV
- ExchangeHE
- CountryFinland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 40.14M
- P/E13.2
- Financial periodFY2025
- RevenueEUR 15.73M
- Revenue growth10.2%
- Net incomeEUR 2.74M
- Free cash flow-EUR 1.36M
- Gross margin68.3%
Valuation Snapshot
latest market cap is EUR 40.14M; P/E is 13.2.
Peer valuation comparison
Latest P/E is 13.2x versus a Healthcare sector median of 24.46x (46.0% below).
Latest P/E is 13.2x versus a Finland median of 18.47x (28.6% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 15.73M | EUR 2.74M | -EUR 1.36M | 68.3% | 0.18 | EUR 3.54M | EUR 1.59M | EUR 14.94M |
| FY2024 | EUR 14.28M | EUR 2.57M | EUR 180.00K | 65.4% | 0.17 | EUR 3.75M | EUR 590.00K | EUR 12.19M |
| FY2023 | EUR 13.08M | EUR 1.85M | EUR 650.00K | 64.7% | 0.12 | EUR 3.27M | EUR 700.00K | EUR 9.43M |
| FY2022 | EUR 10.95M | EUR 600.00K | EUR 1.79M | 64.9% | 0.04 | EUR 2.12M | EUR 940.00K | EUR 7.46M |
| FY2021 | EUR 9.36M | -EUR 1.50M | -EUR 480.00K | 63.2% | -0.1 | EUR 1.10M | EUR 230.00K | EUR 7.30M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | EUR 40.14M | 13.2 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Biohit Oyj B
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company offers GastroPanel quick test NT, a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori and atrophic gastritis; GastroPanel test, a blood test for diagnosis of the function and structure of stomach mucosa;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biohit Oyj B's market cap?
Biohit Oyj B's market capitalization is EUR 40.14M.
What is Biohit Oyj B's P/E ratio?
Biohit Oyj B's price-to-earnings (P/E) ratio is 13.2.
What does Biohit Oyj B do?
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide.